BioSpace News Archive

Design Therapeutics, Inc. reported that João Siffert, M.D., president and chief executive officer, and Sean Jeffries, Ph.D., chief operating officer, will participate in a fireside chat during the SVB Leerink 11th Annual Global Healthcare Conference on Thursday, February 17, 2022 at 11:20 a.m. ET.

InfuSystem Holdings, Inc. today reported preliminary financial results for the fourth quarter and full year ended December 31, 2021.

Cano Health, Inc. will host a conference call on Monday, February 28, 2022 , at 8:30 AM Eastern Time to review the Company’s business and financial results for the fourth quarter and full year 2021 ended December 31, 2021 .

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Caroline Litchfield, executive vice president and chief financial officer, is scheduled to participate in a virtual fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Feb. 17, 2022, at 4:20 p.m. EST.

Theratechnologies Inc. announced today that it will report financial results for its fourth quarter of fiscal 2021 ended November 30, 2021 as well as for its full fiscal year 2021 on Thursday, February 24, 2022.

Agios Pharmaceuticals, Inc. today announced the company will host a conference call and live webcast on Thursday, Feb. 24, 2022, at 8:00 a.m. ET to report its fourth quarter and year end 2021 financial results and other business highlights.

Microbix Biosystems Inc. reports results for its first quarter ended December 31, 2021.

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its fourth quarter and full year 2021 financial results on Thursday, February 24, 2022, and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m.

Arkuda Therapeutics today announced the completion of a $64 million Series B financing.

GentiBio, Inc. today announced the appointment of Chuck Silberstein , M.D., MBA, as Chief Financial Officer (CFO).